Deutsche Bank’s Sophiris Bio, Inc. SPHS Stock Holding History

Deutsche Bank’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-17,524	Closed	-$6K	–	5214
2019 Q4	$6K	Buy	+17,524	New	+$7.96K	﹤0.01%	4646
2017 Q3	–	Sell	-200	Closed	–	–	5355
2017 Q2	$0	Sell	200 -400	-67%	-$980	﹤0.01%	5394
2017 Q1	$1K	Buy	+600	New	+$1.64K	﹤0.01%	4865
2016 Q3	–	Sell	-20,822	Closed	-$44K	–	5572
2016 Q2	$44K	Buy	+20,822	New	+$28.8K	﹤0.01%	4478
2015 Q3	–	Sell	-17,518	Closed	-$13K	–	5638
2015 Q2	$13K	Buy	+17,518	New	+$14.8K	﹤0.01%	5016
2014 Q4	–	Sell	-73,861	Closed	-$216K	–	6620
2014 Q3	$216K	Hold	73,861	–	–	﹤0.01%	4021
2014 Q2	$165K	Hold	73,861	–	–	﹤0.01%	4256
2014 Q1	$245K	Hold	73,861	–	–	﹤0.01%	3789
2013 Q4	$272K	Sell	73,861 -100	-0.1%	-$423	﹤0.01%	3498
2013 Q3	$345K	Buy	+73,961	New	+$341K	﹤0.01%	3769

Other funds holding SPHS

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ACM

AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Deutsche Bank's SPHS Position: Q1 2020 in Review

Deutsche Bank sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 17,524 shares — an estimated $6K sold.

Deutsche Bank first reported a position in SPHS in Q3 2013 and held it in 10 quarters. The position peaked at $345K in Q3 2013. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

Deutsche Bank reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 17,524 Sophiris Bio, Inc. shares in Q1 2020, an estimated $6K.
Deutsche Bank first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 10 quarters.
Deutsche Bank's Sophiris Bio, Inc. position peaked at $345K in Q3 2013.
3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.